Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
12/2012
12/25/2012US8337828 Use of thymosin alpha 1, alone or in combination with PTX3 or ganciclovir, for the treatment of cytomegalovirus infection
12/25/2012US8337826 Active ingredient in a concentrate and a buffer; storage stability; free from human serum albumin
12/25/2012US8337824 Linear polyol stabilized polyfluoroacrylate compositions
12/25/2012US8337816 Comprising inhalable medicament particles having a mass median aerodynamic diameter no greater than 10 mu m and 50% of a non-respirable excipient fraction comprising low density excipient particles having an aerodynamic diameter greater than 10 mu m and a geometric diameter greater than 30 mu m
12/20/2012WO2012174559A1 Inhalable pharmaceutical compositions
12/20/2012WO2012174555A2 Composition and method for stabilization and delivery of therapeutic molecules
12/20/2012WO2012173933A2 Activatable nanoprobes for intracellular drug delivery
12/20/2012WO2012173621A1 Multi-layer capsule and manufacture method thereof
12/20/2012WO2012173422A1 A conjugate comprising oxyntomodulin and an immunoglobulin fragment, and use thereof
12/20/2012WO2012173392A2 Curcuminoid-based compound/stevioside-containing complex for the prevention and treatment of an influenza virus infection
12/20/2012WO2012173288A1 Magnetic resonance imaging t2 contrast medium for cell contrasting, and method for manufacturing same
12/20/2012WO2012173226A1 Pharmaceutical preparation containing polystyrenesulfonic acid salt
12/20/2012WO2012173003A2 Medical tissue-marker and manufacturing method for same
12/20/2012WO2012172892A1 Metal salen complex compound, local anesthetic, and anti-malignant tumor agent
12/20/2012WO2012172457A1 Novel lipidomimetic compounds and uses thereof
12/20/2012WO2012172433A2 A sustained-release composition containing peptides as active ingredient
12/20/2012WO2012172413A1 Pharmaceutical composition comprising a combination of eperisone and diclofenac and process for preparing thereof
12/20/2012WO2012171561A1 Stabilized voriconazole composition
12/20/2012WO2012171364A1 Oil-soluble pharmaceutical composition
12/20/2012WO2012171335A1 Multi-vinylsulfone containing molecule
12/20/2012WO2012171125A1 N,n,n-trialkylpolymers, methods of their preparation and uses thereof
12/20/2012WO2012171084A1 Polymer insulin encapsulation system, process and use of said system
12/20/2012WO2012148181A3 Composition for the controlled-release of drugs
12/20/2012WO2012140433A9 System for purifying, producing and storing biomelecules
12/20/2012WO2012102538A3 Dry syrup composition
12/20/2012WO2011102724A3 Disinfectant composition and its use in dental treatment
12/20/2012US20120323162 Methods and Compositions for Treating Conditions of the Eye
12/20/2012US20120322895 Biodegradable polymeric networks and methods for manufacturing the same
12/20/2012US20120322894 Direct Compression Polymer Tablet Core
12/20/2012US20120322893 Coarse support silica particles
12/20/2012US20120322825 Aqueous liquid preparations and light-stabilized aqueous liquid preparations
12/20/2012US20120322750 Solubilization agent for solubilizing polyphenols, flavonoids and/or diterpenoid glucosides
12/20/2012US20120322720 Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles
12/20/2012US20120322718 Amygels in organic solvent for biomedical applications
12/20/2012US20120322134 Branched polymers
12/20/2012US20120321716 Technology for preventing abuse of solid dosage forms
12/20/2012US20120321710 Controlled Release and Taste Masking Oral Pharmaceutical Composition
12/20/2012US20120321685 Compositions containing oils having a specific gravity higher than the specific gravity of water
12/20/2012US20120321669 Antigenic compositions
12/20/2012US20120321651 Anti-IGE Vaccines
12/20/2012US20120321616 Stabilized liquid anti-rsv antibody formulations
12/20/2012US20120321604 Carrier comprising non-neutralised tocopheryl phosphate
12/20/2012US20120321603 Composition and method for stabilization and delivery of therapeutic molecules
12/20/2012US20120321596 Kit for adhering biological hard tissues
12/20/2012US20120321583 Protein-Polymer-Drug Conjugates
12/20/2012US20120321574 Anhydrous topical skin preparations
12/20/2012US20120321569 Water-absorbent adhesive compositions and associated methods of manufacture and use
12/20/2012US20120321565 Pharmaceutical compositions comprising 17alpha-furanylesters of 17beta-carbothiate androstanes with a muscarinic receptor antagonist
12/20/2012US20120321552 Compositions and Methods for Identifying and Targeting Cancer Cells of Alimentary Canal Origin
12/20/2012US20120318701 Polymeric reagents comprising a terminal vinylic group and conjugates formed therefrom
12/20/2012CA2839408A1 Aromatic-cationic peptides and uses of same
12/20/2012CA2839270A1 Inhalable pharmaceutical compositions
12/20/2012CA2839200A1 Medical tissue-marker and manufacturing method for same
12/20/2012CA2839063A1 Activatable nanoprobes for intracellular drug delivery
12/20/2012CA2838504A1 A conjugate comprising oxyntomodulin and an immunoglobulin fragment, and use thereof
12/20/2012CA2838326A1 Multi-layer capsule and manufacture method thereof
12/20/2012CA2833676A1 A sustained-release composition containing peptides as active ingredient
12/19/2012EP2535347A1 Polymer conjugates with decreased antigenicity, methods of preparation and uses thereof
12/19/2012EP2535326A1 Novel lipidomimetic compounds and uses thereof
12/19/2012EP2535087A2 Cosmetic, pharmaceutical or nutraceutical formulations containing antioxidant molecules and polymeric materials
12/19/2012EP2535048A1 Extended release preparation
12/19/2012EP2534200A1 Cross-linked oxidated hyaluronic acid for use as a vitreous substitute
12/19/2012EP2533815A1 Nucleic acid complexes
12/19/2012EP2533814A2 Delivery of immunoglobulin variable domains and constructs thereof
12/19/2012EP2533813A1 Igf-i poly (ethylene glycol) conjugates
12/19/2012EP2533812A2 Anionic polysaccharides functionalised by at least two hydrophobic groups supported by an at least trivalent spacer
12/19/2012EP2533810A1 Cd20 antibodies and uses thereof
12/19/2012EP2533804A1 Antibody drug conjugates (adc) that bind to 161p2f10b proteins
12/19/2012EP2533789A1 Methods for improving sperm functionality
12/19/2012EP2533788A1 Stable solution
12/19/2012EP2533763A2 Dermatological, pharmaceutical composition suitable for oligonucleotides
12/19/2012EP2533761A2 Methods and compositions for the preparation of aerosols
12/19/2012EP2533760A1 Liquid composition comprising a non-menthol cooling agent and a thickener for treating a respiratory symptom
12/19/2012CN202605114U Medical flocked hemostasis material
12/19/2012CN102834512A Metal salen complex derivative and process for production thereof
12/19/2012CN102834118A Composition comprising the amyloid beta 1-6 peptide coupled to virus-like particle and an adjuvant
12/19/2012CN102834117A Anionic polysaccharides functionalised by at least two hydrophobic groups supported by an at least trivalent spacer
12/19/2012CN102834116A Treatment of WNT/frizzled-related diseases
12/19/2012CN102834109A Stable growth hormone compounds
12/19/2012CN102834096A Solid-forming local anesthetic formulations for pain control
12/19/2012CN102834093A Transdermally absorbed preparation of anti-dementia drug
12/19/2012CN102834092A Transdermally absorbed preparation of anti-dementia drug
12/19/2012CN102834090A Acetaminophen composition
12/19/2012CN102834025A Method for altering the flavor of a food product
12/19/2012CN102827446A Temperature response type injectable hydrogel and preparation method and usage thereof
12/19/2012CN102827365A Amino acid connected with polyethylene glycol and preparation method and application for amino acid
12/19/2012CN102827324A Nano-hydrogel with micro electric field response function and preparation method and application thereof
12/19/2012CN102827307A Beta-cyclodextrin-modified tetrahydro-beta-carboline carboxylic acid derivatives, and preparation method and application thereof
12/19/2012CN102827293A Alkynyl hydroxypropyl cellulose and preparation method and application of temperature-sensitive hydrogel of alkynyl hydroxypropyl cellulose
12/19/2012CN102827291A Recombinant fusion protein PTD-HSP27 and use thereof
12/19/2012CN102827288A Acid-activated CSP targeted antimicrobial peptide and preparation method and applications thereof
12/19/2012CN102827286A Fusion protein of Exendin-4 and mutational human serum albumin, and preparation method of fusion protein
12/19/2012CN102827285A Mouse-specific anti-fertility polypeptide
12/19/2012CN102827284A Exendin or analogue containing polyethylene glycol group and preparation and application thereof
12/19/2012CN102827277A Anti-human serum albumin single-chain antibody and method for connecting polypeptide drugs to carbon end thereof
12/19/2012CN102827272A Folate coupling antibody drug and its preparation method and use
12/19/2012CN102827270A Pegylated exenatide ramification and use thereof
12/19/2012CN102827254A Cell penetrating peptide hPP10 and use thereof
12/19/2012CN102827251A Transmembrane peptide-mediated antisense antibacterial agent and preparation method and application thereof
12/19/2012CN102826524A Mesoporous hydroxyapatite nonoparticles prepared by microwave-ultrasonic method, and application thereof
1 ... 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 ... 1712